1. Home
  2. AVDL vs HSTM Comparison

AVDL vs HSTM Comparison

Compare AVDL & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • HSTM
  • Stock Information
  • Founded
  • AVDL 2015
  • HSTM 1990
  • Country
  • AVDL Ireland
  • HSTM United States
  • Employees
  • AVDL N/A
  • HSTM N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • HSTM Computer Software: Programming Data Processing
  • Sector
  • AVDL Health Care
  • HSTM Technology
  • Exchange
  • AVDL Nasdaq
  • HSTM Nasdaq
  • Market Cap
  • AVDL 861.4M
  • HSTM 828.5M
  • IPO Year
  • AVDL 1996
  • HSTM 2000
  • Fundamental
  • Price
  • AVDL $12.75
  • HSTM $25.98
  • Analyst Decision
  • AVDL Strong Buy
  • HSTM Hold
  • Analyst Count
  • AVDL 7
  • HSTM 2
  • Target Price
  • AVDL $19.00
  • HSTM $28.00
  • AVG Volume (30 Days)
  • AVDL 1.2M
  • HSTM 178.5K
  • Earning Date
  • AVDL 08-07-2025
  • HSTM 08-04-2025
  • Dividend Yield
  • AVDL N/A
  • HSTM 0.48%
  • EPS Growth
  • AVDL N/A
  • HSTM 14.03
  • EPS
  • AVDL N/A
  • HSTM 0.67
  • Revenue
  • AVDL $221,075,000.00
  • HSTM $295,211,000.00
  • Revenue This Year
  • AVDL $56.78
  • HSTM $5.00
  • Revenue Next Year
  • AVDL $30.46
  • HSTM $5.20
  • P/E Ratio
  • AVDL N/A
  • HSTM $38.70
  • Revenue Growth
  • AVDL 132.35
  • HSTM 3.50
  • 52 Week Low
  • AVDL $6.38
  • HSTM $25.36
  • 52 Week High
  • AVDL $17.30
  • HSTM $34.24
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 76.98
  • HSTM 41.18
  • Support Level
  • AVDL $10.79
  • HSTM $25.55
  • Resistance Level
  • AVDL $14.23
  • HSTM $26.47
  • Average True Range (ATR)
  • AVDL 0.59
  • HSTM 0.52
  • MACD
  • AVDL 0.14
  • HSTM -0.02
  • Stochastic Oscillator
  • AVDL 61.15
  • HSTM 33.70

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About HSTM HealthStream Inc.

HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.

Share on Social Networks: